Many factors can influence posttransplant lipid profile including age, genetic predisposition, obesity, reduced physical activity, diet, and use of immunosuppressive agents (including calcineurin inhibitors, primarily cyclosporine, corticosteroids, and mammalian target of rapamycin inhibitors) [23]. The gene discussed is MTOR; the disease is obesity disorder.